Journal
JOURNAL OF NEUROINFLAMMATION
Volume 12, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s12974-015-0270-3
Keywords
Experimental stroke; Inflammation; Malibatol A; Microglia; M1/M2; PPAR gamma
Categories
Funding
- National Natural Science Foundation of China [81171085, 81230026, 81300988]
- Natural Science Foundation of Jiangsu Province of China [BL2012013]
- Medical Leading Talent and Innovation Team Project of Jiangsu Province [LJ201101]
Ask authors/readers for more resources
Background: Activation of microglia plays a crucial role in immune and inflammatory processes after ischemic stroke. Microglia is reported with two opposing activated phenotypes, namely, classic phenotype (M1) and the alternative phenotype (M2). Inhibiting M1 while stimulating M2 has been suggested as a potential therapeutic approach in the treatment of stroke. Findings: In this study, we indicated that a novel natural anti-oxidant extracted from the Chinese plant Hopea hainanensis, malibatol A (MA), decreased the infarct size and alleviated the brain injury after mice middle cerebral artery occlusion (MCAO). MA inhibited expression inflammatory cytokines in not only MCAO mice but also lipopolysaccharide (LPS)-stimulated microglia. Moreover, treatment of MA decreased M1 markers (CD16, CD32, and CD86) and increased M2 markers (CD206, YM-1) while promoting the activation of nuclear receptor PPAR gamma. Conclusions: MA has anti-inflammatory effects in MCAO mice in a PPAR gamma-dependent manner, making it a potential candidate for stroke treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available